CFMT, Inc. v. YieldUP International Corp.’s Empirical Analysis

Citation profile

10 federal appellate · 9 district ·

Most-quoted passages

The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 47 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.

1. “Improvement and selection inventions are ubiquitous in patent law; such developments do not alone cast doubt on enablement of the original invention. In general, few patented inventions are an immediate commercial success. Rather, most inventions require further development to achieve commercial success. Thus, additional inventive work does not alone show nonenablement.”

   2 later decisions quote this exact passage · from the majority
   e.g. Abiomed, Inc. v. Maquet Cardiovascular LLC · 876 F. Supp. 2d 857 - Westerngeco L.L.C. v. Ion Geophysical Corp.

2. “During prosecution, an applicant may submit objective factual evidence to the PTO in the form of patents, technical literature, and declarations.... The advantages advocacy in this case does not fit any of these categories and was unaccompanied by and not asserted to be supported by any factual evidence. Therefore, a reasonable examiner would not have found it important in deciding whether to allow the application.”

   1 later decision quote this exact passage · from the majority
   e.g. 363 F. Supp. 2d 514 - In Re Ciprofloxacin Hydrochloride Antitrust Litigation

3. “[b]ecause the preamble term 'cleaning' means only 'removal of contaminants,' not removal of all contaminants or removal of contaminants according to [a] commercial standard, the inventor shows utility and enables the invention by disclosing 'removal of contaminants'”

   1 later decision quote this exact passage · from the majority
   e.g. Barry v. Medtronic, Inc.